Drug Concentrations and Anti-drug Antibodies Influence in Response to Adalimumab: Results from the BioEfficacySpA Clinical Trial

被引：0

作者：

Marona, Jose ^{[1
,2
]}

Rodrigues-Manica, Santiago ^{[3
]}

Gomes, Joao Lagoas ^{[1
,2
]}

Lopes, Carina ^{[1
,2
]}

Iria, Ines ^{[4
]}

Bernardes, Miguel ^{[5
]}

Santos, Helena ^{[6
]}

Tavares-Costa, Jose ^{[7
]}

Madruga-Dias, Joao ^{[8
]}

Pinto, Patricia ^{[9
]}

Bernardo, Alexandra ^{[10
]}

Maia, Sara ^{[2
]}

Branco, Jaime ^{[3
]}

Goncalves, Joao ^{[4
]}

Pimentel-Santos, Fernando ^{[3
]}

机构：

[1] Hosp Egas Moniz, Rheumatol Dept, Ctr Hosp Lisboa Ocidental, Lisbon, Portugal

[2] NOVA Med Sch, Fac Ciencias Med, CEDOC, Lisbon, Portugal

[3] Hosp Egas Moniz, NOVA Med Sch, CEDOC, CHLO, Lisbon, Portugal

[4] Univ Lisbon, Fac Farm, Lisbon, Portugal

[5] Ctr Hosp Sao Joao, Rheumatol, Porto, Portugal

[6] IPR, Lisbon, Portugal

[7] ULSAM, Ponte do Lima, Portugal

[8] CHMT, Torres Novas, Portugal

[9] CHVNG, Rheumatol Dept, Vila Nova De Gaia, Portugal

[10] CHSJ, Rheumatol Dept, Porto, Portugal

来源：

ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0586

引用

页数：2

共 50 条

[1] Factors that may influence the development of anti-drug antibodies to adalimumab
Reinisch, W.
Rauter, I.
Chen, L.
Gessner, M.
Fanjiang, G.
[J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S429 - S430
[2] Adalimumab Serum Concentrations or Anti-Drug Antibodies Do Not Influence Fatigue in Patients with Crohn's Disease
Karlsen, Lars Normann
Carlsen, Arne
Omdal, Roald
Aabakken, Lars
Bolstad, Nils
Lundin, Knut
Grimstad, Tore
[J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S44 - S45
[3] Concentrations of infliximab and anti-drug antibodies in relation to clinical response in patients with rheumatoid arthritis
Siljehult, F.
Arlestig, L.
Eriksson, C.
Rantapaa-Dahlqvist, S.
[J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (05) : 345 - 350
[4] Adalimumab/infliximabDevelopment of anti-drug antibodies: 7 case reports
[J]. Reactions Weekly, 2018, 1701 (1) : 15 - 15
[5] Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab
Gorovits, B.
Baltrukonis, D. J.
Bhattacharya, I
Birchler, M. A.
Finco, D.
Sikkema, D.
Vincent, M. S.
Lula, S.
Marshall, L.
Hickling, T. P.
[J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 192 (03): : 348 - 365
[6] Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases
Jyssum, Ingrid
Gehin, Johanna E.
Sexton, Joseph
Kristianslund, Eirik Klami
Hu, Yi
Warren, David John
Kvien, Tore K.
Haavardsholm, Espen A.
Syversen, Silje Watterdal
Bolstad, Nils
Goll, Guro Lovik
[J]. RHEUMATOLOGY, 2024, 63 (06) : 1746 - 1755
[7] The early appearance of anti-drug antibodies during the induction phase predicts the clinical response of adalimumab and infliximab in IBD
Roblin, X.
Williet, N.
Veyrard, P.
Boschetti, G.
Berger, A. E.
Nancey, S.
Flourie, B.
Paul, S.
[J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S369 - S369
[8] THE EARLY APPEARANCE OF ANTI-DRUG ANTIBODIES DURING THE INDUCTION PHASE PREDICTS THE CLINICAL RESPONSE OF ADALIMUMAB AND INFLIXIMAB IN IBD
Roblin, Xavier
Williet, Nicolas
Flourie, Bernard
Berger, Anne
Ben-Horin, Shomron
Paul, Stephane
[J]. GASTROENTEROLOGY, 2020, 158 (06) : S47 - S47
[9] Adalimumab/methotrexateLack of efficacy and development of anti-drug antibodies : case report
[J]. Reactions Weekly, 2018, 1724 (1) : 18 - 18
[10] Long Persistence of Anti-Drug Antibodies in Adalimumab Treated RA Patients
Kekow, Joern
Drynda, Susanne
[J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68

← 1 2 3 4 5 →